Paper36978398
Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
Martínez-Casanova J and 12 others. Antibiotics (Basel), 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients. Papers, record 36978398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978398
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26754759 | Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. | Intensive Care Med | 2016 | https://conductscience.org/library/papers/26754759 | PubMed |
| 2 | 33042550 | Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials. | J Intensive Care | 2020 | https://conductscience.org/library/papers/33042550 | PubMed |
| 3 | 34131869 | Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure? | Eur J Drug Metab Pharmacokinet | 2021 | https://conductscience.org/library/papers/34131869 | PubMed |
| 4 | 17785973 | Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion. | Chemotherapy | 2007 | https://conductscience.org/library/papers/17785973 | PubMed |
| 5 | 23074313 | Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23074313 | PubMed |
| 6 | 21302010 | Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. | AAPS J | 2011 | https://conductscience.org/library/papers/21302010 | PubMed |
| 7 | 22194591 | Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. | Chest | 2012 | https://conductscience.org/library/papers/22194591 | PubMed |
| 8 | 27476810 | Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients. | Int J Antimicrob Agents | 2016 | https://conductscience.org/library/papers/27476810 | PubMed |
| 9 | 19237898 | Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration? | Crit Care Med | 2009 | https://conductscience.org/library/papers/19237898 | PubMed |
| 10 | 19252334 | Mechanistic basis of using body size and maturation to predict clearance in humans. | Drug Metab Pharmacokinet | 2009 | https://conductscience.org/library/papers/19252334 | PubMed |
| 11 | 26200166 | A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. | Am J Respir Crit Care Med | 2015 | https://conductscience.org/library/papers/26200166 | PubMed |
| 12 | 25038549 | The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. | Adv Drug Deliv Rev | 2014 | https://conductscience.org/library/papers/25038549 | PubMed |
| 13 | 28571493 | Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective? | Expert Rev Anti Infect Ther | 2017 | https://conductscience.org/library/papers/28571493 | PubMed |
| 14 | 24768475 | Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. | Lancet Infect Dis | 2014 | https://conductscience.org/library/papers/24768475 | PubMed |
| 15 | 25881576 | A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. | Crit Care | 2015 | https://conductscience.org/library/papers/25881576 | PubMed |
| 16 | 6225390 | Pharmacokinetics of piperacillin in subjects with various degrees of renal function. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6225390 | PubMed |
| 17 | 29102324 | Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. | Lancet Infect Dis | 2018 | https://conductscience.org/library/papers/29102324 | PubMed |
| 18 | 29791023 | Comparison of the Cockcroft-Gault, MDRD and CKD-EPI equations for estimating ganciclovir clearance. | Br J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29791023 | PubMed |
| 19 | 16023764 | PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. | Comput Methods Programs Biomed | 2005 | https://conductscience.org/library/papers/16023764 | PubMed |
| 20 | 25643277 | Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development. | Semin Respir Crit Care Med | 2015 | https://conductscience.org/library/papers/25643277 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42171260 | Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring. | Anal Methods | 2026 | https://conductscience.org/library/papers/42171260 | PubMed |
| 41858912 | Population Pharmacokinetics and Dosing Regimen Optimization of Piperacillin in Critically Ill Patients. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41858912 | PubMed |
| 40001445 | Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40001445 | PubMed |
| 39992534 | Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints. | Eur J Clin Microbiol Infect Dis | 2025 | https://conductscience.org/library/papers/39992534 | PubMed |
| 39473921 | Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis. | Crit Care Res Pract | 2024 | https://conductscience.org/library/papers/39473921 | PubMed |
| 39334976 | Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39334976 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CTRC | 11330 | PubTator's text mining | https://conductscience.org/library/genes/11330 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978398
GET https://conductscience.org/api/papers/v1/36978398/references?page=2